LWCFA
CRTX

Loring Wolcott & Coolidge Fiduciary Advisors’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-12
Closed – – 654
2013
Q4 		$0 Hold
12
– – ﹤0.01% 633
2013
Q3 		$0 Hold
12
– – ﹤0.01% 579
2013
Q2 		$0 Buy
+12
New +$101 ﹤0.01% 597

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's CRTX Position: Q1 2014 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 12 shares.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $0 in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 12 CORNERSTONE THERAPEUTICS INC shares in Q1 2014.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's CORNERSTONE THERAPEUTICS INC position peaked at $0 in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2014, filed 28 Apr 2014.